JESSICA STAPLES: Open Payments
NPI 1760014153 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 30 payments from 11 companies in 2025. Trend: 2023 $533 · 2024 $939 · 2025 $756
Food & beverage: $756
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $177 |
| Novo Nordisk Inc | 3 | $168 |
| PFIZER INC. | 4 | $64 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Amgen Inc. | 4 | $59 |
| Lilly USA, LLC | 2 | $55 |
| ABBVIE INC. | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Dexcom, Inc. | 2 | $33 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
Products named: Wegovy, AIRSUPRA, TRELEGY ELLIPTA, OTEZLA, ELIQUIS, JARDIANCE, MOUNJARO, Dexcom G6 Transmitter.
Industry payments across VA — which companies pay providers there.
